Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
Ben-Menachem, Elinor, Mameniškienė, Rūta, Quarato, Pier Paolo, Klein, Pavel, Gamage, Jessica, Schiemann, Jimmy, Johnson, Martin E, Whitesides, John, McDonough, Belinda, Eckhardt, Klaus
Published in Neurology (19.07.2016)
Published in Neurology (19.07.2016)
Get more information
Journal Article
Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: pooled results from three Phase III studies
Moseley, Brian D., MD, Sperling, Michael R., MD, Asadi-Pooya, Ali A., MD, Diaz, Anyzeila, PharmD, Elmouft, Sami, MSc, Schiemann, Jimmy, MD, Whitesides, John, PhD
Published in Epilepsy research (01.11.2016)
Published in Epilepsy research (01.11.2016)
Get full text
Journal Article
A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizures
Klein, Pavel, Schiemann, Jimmy, Sperling, Michael R., Whitesides, John, Liang, Wei, Stalvey, Tracy, Brandt, Christian, Kwan, Patrick
Published in Epilepsia (Copenhagen) (01.12.2015)
Published in Epilepsia (Copenhagen) (01.12.2015)
Get full text
Journal Article
Safety, tolerability, and seizure control during long‐term treatment with adjunctive brivaracetam for partial‐onset seizures
Toledo, Manuel, Whitesides, John, Schiemann, Jimmy, Johnson, Martin E., Eckhardt, Klaus, McDonough, Belinda, Borghs, Simon, Kwan, Patrick
Published in Epilepsia (Copenhagen) (01.07.2016)
Published in Epilepsia (Copenhagen) (01.07.2016)
Get full text
Journal Article
Time to onset of sustained ≥50% responder status in patients with focal (partial‐onset) seizures in three phase III studies of adjunctive brivaracetam treatment
Klein, Pavel, Johnson, Martin E., Schiemann, Jimmy, Whitesides, John
Published in Epilepsia (Copenhagen) (01.02.2017)
Published in Epilepsia (Copenhagen) (01.02.2017)
Get full text
Journal Article
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials
Silberstein, Stephen D., McAllister, Peter, Ning, Xiaoping, Faulhaber, Nicola, Lang, Nicole, Yeung, Paul, Schiemann, Jimmy, Aycardi, Ernesto, Cohen, Joshua M., Janka, Lindsay, Yang, Ronghua
Published in Headache (01.06.2019)
Published in Headache (01.06.2019)
Get full text
Journal Article
Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies
Brodie, Martin J, Whitesides, John, Schiemann, Jimmy, D’souza, Joseph, Johnson, Martin E
Published in Epilepsy research (01.11.2016)
Published in Epilepsy research (01.11.2016)
Get full text
Journal Article
Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis
Benbadis, Selim, Klein, Pavel, Schiemann, Jimmy, Diaz, Anyzeila, Elmoufti, Sami, Whitesides, John
Published in Epilepsy & behavior (01.03.2018)
Published in Epilepsy & behavior (01.03.2018)
Get full text
Journal Article
Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study
Asadi-Pooya, Ali A, Sperling, Michael R, Chung, Steve, Klein, Pavel, Diaz, Anyzeila, Elmoufti, Sami, Schiemann, Jimmy, Whitesides, John
Published in Epilepsy research (01.03.2017)
Published in Epilepsy research (01.03.2017)
Get full text
Journal Article
Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: Subpopulation analysis of a prospective, open-label extension study of up to 48 weeks
Piña-Garza, Jesus Eric, MD, Schiemann-Delgado, Jimmy, MD, Yang, Haichen, MD, Duncan, Benjamin, MS, Hadac, Jan, MD, Hunter, Scott J., PhD
Published in Clinical therapeutics (01.10.2010)
Published in Clinical therapeutics (01.10.2010)
Get full text
Journal Article
Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: A double-blind, randomised, multicentre, historical control study
Chung, Steve, Ceja, Hugo, Gawłowicz, Jacek, Avakyan, Gagik, McShea, Cindy, Schiemann, Jimmy, Lu, Sarah
Published in Epilepsy research (01.08.2012)
Published in Epilepsy research (01.08.2012)
Get full text
Journal Article
Erratum to “Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study” [Epilepsy Res. 131 (2017) 70–75]
Asadi-Pooya, Ali A, Sperling, Michael R, Chung, Steve, Klein, Pavel, Diaz, Anyzeila, Elmoufti, Sami, Schiemann, Jimmy, Whitesides, John
Published in Epilepsy research (01.11.2017)
Published in Epilepsy research (01.11.2017)
Get full text
Journal Article
Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial
de la Loge, Christine, Hunter, Scott J, Schiemann, Jimmy, Yang, Haichen
Published in Epilepsy & behavior (01.07.2010)
Published in Epilepsy & behavior (01.07.2010)
Get full text
Journal Article
A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures
Schiemann-Delgado, Jimmy, Yang, Haichen, Loge, Christine de la, Stalvey, Tracy J, Jones, John, Legoff, Daniel, Mintz, Mark
Published in Journal of child neurology (01.01.2012)
Published in Journal of child neurology (01.01.2012)
Get more information
Journal Article